Marshwinds Advisory’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Marshwinds Advisory's AMGN Position: Q4 2018 in Review
Marshwinds Advisory reduced its Amgen (AMGN) stake by 3.8% in Q4 2018, selling an estimated $197K and leaving 25,441 shares worth $4.95M. The position accounts for 2.65% of the portfolio, ranked #5.
Marshwinds Advisory first reported a position in AMGN in Q2 2013 and has held it in 23 quarters since. The position peaked at $5.62M in Q4 2014. 1,892 funds tracked by Wall St. Rank hold AMGN as of Q4 2018.
- Marshwinds Advisory held 25,441 shares of Amgen worth $4.95M as of Q4 2018.
- Marshwinds Advisory sold 1,009 Amgen shares in Q4 2018, an estimated $197K.
- Amgen made up 2.65% of Marshwinds Advisory's portfolio in Q4 2018, its #5 holding.
- Marshwinds Advisory first reported a position in Amgen in Q2 2013 and has held it in 23 quarters since.
- Marshwinds Advisory's Amgen position peaked at $5.62M in Q4 2014.
- 1,892 funds tracked by Wall St. Rank held Amgen as of Q4 2018.
Based on Marshwinds Advisory's 13F filing for Q4 2018, filed 7 Jan 2019.